Cardinal Health, Inc.
CAH · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $222,578,000 | $226,827,000 | $204,979,000 | $181,326,000 |
| % Growth | -1.9% | 10.7% | 13% | – |
| Cost of Goods Sold | $214,410,000 | $219,413,000 | $198,105,000 | $174,842,000 |
| Gross Profit | $8,168,000 | $7,414,000 | $6,889,000 | $6,484,000 |
| % Margin | 3.7% | 3.3% | 3.4% | 3.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,382,000 | $5,000,000 | $4,800,000 | $4,512,000 |
| Sales & Mktg Exp. | $5,382,000 | $5,000,000 | $0 | $0 |
| Other Operating Expenses | $511,000 | $1,171,000 | $1,322,000 | $2,579,000 |
| Operating Expenses | $5,893,000 | $6,171,000 | $6,122,000 | $7,091,000 |
| Operating Income | $2,275,000 | $1,243,000 | $752,000 | -$607,000 |
| % Margin | 1% | 0.5% | 0.4% | -0.3% |
| Other Income/Exp. Net | -$174,000 | -$42,000 | -$89,000 | -$177,000 |
| Pre-Tax Income | $2,101,000 | $1,201,000 | $663,000 | -$784,000 |
| Tax Expense | $532,000 | $348,000 | $332,000 | $153,000 |
| Net Income | $1,561,000 | $852,000 | $330,000 | -$938,000 |
| % Margin | 0.7% | 0.4% | 0.2% | -0.5% |
| EPS | 6.48 | 3.48 | 1.26 | -3.34 |
| % Growth | 86.2% | 176.2% | 137.7% | – |
| EPS Diluted | 6.45 | 3.45 | 1.26 | -3.34 |
| Weighted Avg Shares Out | 241,000 | 245,000 | 261,000 | 279,000 |
| Weighted Avg Shares Out Dil | 242,000 | 247,000 | 262,000 | 279,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $215,000 | $51,000 | $84,000 | $147,000 |
| Depreciation & Amortization | $790,000 | $710,000 | $692,000 | $692,000 |
| EBITDA | $3,106,000 | $1,962,000 | $1,439,000 | $55,000 |
| % Margin | 1.4% | 0.9% | 0.7% | 0% |